EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Brief international cognitive assessment for MS ( BICAMS ) and NEDA maintenance in MS patients: A 2‐year follow‐up longitudinal study

E Leveraro iD, M Cellerino iD, C Lapucci iD, M Dighero, L Nasone, T Sirito, D Boccia iD, N Cavalli, G Bavestrello, A Uccelli, G Boffa, M Inglese iD

European Journal of Neurology · 2025

DOI: 10.1111/ene.70007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, 2025. Verfasst von E Leveraro und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, and Mother-Child Health (DINOGMI), University of Genoa, Genoa, Italy. Hauptthemen laut MEDLINE: Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Università e della Ricerca, Fondazione Italiana Sclerosi Multipla, Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) has been validated in many cross‐sectional studies. However, longitudinal data on BICAMS subset trajectories and their correlation with disease activity during follow‐up are scarce.

Objectives

We aimed to (i) assess BICAMS changes in MS patients initiating high‐efficacy disease‐modifying‐treatments (DMTs), (ii) compare these changes based on maintenance of “no‐evidence‐of‐disease‐activity” (NEDA‐3) status over 24 months, and (iii) determine baseline clinical parameters predictive of cognitive changes.

Methods

We enrolled 101 MS patients (mean age:40,45 ± 11; Relapsing–Remitting‐MS:81%) initiating highly‐effective‐DMTs. Patients underwent Expanded Disability Status Scale (EDSS), BICAMS, and Hospital Anxiety and Depression Scale (HADS), at baseline and after 24 months. Regression‐based change index (RB‐CI) had been used for cognitive change evaluation over follow‐up.

Results

During follow‐up, 78 (77.3%) patients maintained NEDA‐3 status. Considering a 90% of confidence levels for RB‐CI, 12 (11.9%) improved at SDMT, 13 (12.9%) at CVLT‐II and 13 (12.9%) at BVMT‐R; while 7 (6.9%) were classified as worsened at SDMT, 11 (10.9%) at CVLT‐II and 8 (7.9%) at BVMT‐R. SDMT scores significantly improved at follow‐up for the entire group ( p = 0.003) and in patients maintaining NEDA‐3 ( p < 0.001). The multivariable regression model assessing the SDMT improvement ( n = 12; z = 1.65), was significant and explained 21% of the variance ( p = 0.038; Nagelkerke R 2 = 0.212). Lower EDSS proved to be an independent predictor of SDMT reliable improvement ( p = 0.027) in our sample.

Conclusions

Our findings showed that early disease activity control—especially in patients with low baseline disability—may yield significant benefits even in terms of cognitive performance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionHumansMaleFemaleAdultMiddle AgedLongitudinal StudiesFollow-Up StudiesMultiple Sclerosis, Relapsing-RemittingNeuropsychological TestsMultiple Sclerosis

Stichwörter der Autor:innen

BICAMScognitive impairmenthigh‐efficacy therapymultiple sclerosis

Autor:innen und Institutionen

  • Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, and Mother-Child Health (DINOGMI), University of Genoa, Genoa, Italy.
  • IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

ORCID-Profile: E Leveraro, M Cellerino, C Lapucci, D Boccia, M Inglese

Förderung

  • Ministero dell'Università e della Ricerca
  • Fondazione Italiana Sclerosi Multipla
  • Ministero della Salute

Zitieren

APA

Leveraro, E., Cellerino, M., Lapucci, C., Dighero, M., Nasone, L., Sirito, T., Boccia, D., Cavalli, N., Bavestrello, G., Uccelli, A., Boffa, G., & Inglese, M. (2025). Brief international cognitive assessment for MS ( BICAMS ) and NEDA maintenance in MS patients: A 2‐year follow‐up longitudinal study. European Journal of Neurology. https://doi.org/10.1111/ene.70007

Vancouver

Leveraro E, Cellerino M, Lapucci C, Dighero M, Nasone L, Sirito T, et al. Brief international cognitive assessment for MS ( BICAMS ) and NEDA maintenance in MS patients: A 2‐year follow‐up longitudinal study. European Journal of Neurology. 2025. doi:10.1111/ene.70007

BibTeX
@article{Leveraro2025,
  author = {Leveraro, E and Cellerino, M and Lapucci, C and Dighero, M and Nasone, L and Sirito, T and Boccia, D and Cavalli, N and Bavestrello, G and Uccelli, A and Boffa, G and Inglese, M},
  title = {Brief international cognitive assessment for MS ( BICAMS ) and NEDA maintenance in MS patients: A 2‐year follow‐up longitudinal study},
  journal = {European Journal of Neurology},
  year = {2025},
  doi = {10.1111/ene.70007}
}
Kostenlos starten →